2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

BACKGROUND: Combination β-lactam and vancomycin (VAN) prevent the emergence of resistance and result in synergistic antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) in vitro. We sought to provide clinical translation to these data and determine if patients with MRSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorgensen, Sarah C J, Trinh, Trang D, Zasowski, Evan J, Alosaimy, Sara, Melvin, Sarah, Bhatia, Sahil, Dhar, Sorabh, Mynatt, Ryan P, Pogue, Jason M, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810267/
http://dx.doi.org/10.1093/ofid/ofz360.1928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810267/
http://dx.doi.org/10.1093/ofid/ofz360.1928

Ejemplares similares